These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 11565217)

  • 21. [Meningococcal infections in Belgium. Current status and proposal for a surveillance system. Study group on meningococcal infections charged with vaccination problems].
    De Maeyer-Cleempoel S; De Wals P
    Arch Belg Med Soc; 1978 Feb; 36(2):65-76. PubMed ID: 708035
    [No Abstract]   [Full Text] [Related]  

  • 22. Epidemiology of meningococcal disease in Switzerland, 1999-2002.
    Ruedin HJ; Ninet B; Pagano E; Rohner P
    Eur J Clin Microbiol Infect Dis; 2004 Jul; 23(7):517-22. PubMed ID: 15221618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Meningococcal disease in Australia: 1997 and beyond.
    Harvey BM
    Commun Dis Intell; 1998 Jul; 22(7):134-5. PubMed ID: 9684531
    [No Abstract]   [Full Text] [Related]  

  • 24. [Meningococcal disease. new prevention strategies].
    Soult Rubio JA; Muñoz Sáez M; López Castilla JD
    An Esp Pediatr; 2001 Jan; 54(1):65-8. PubMed ID: 11181197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meningococcal disease in catalonia 1 year after mass vaccination campaign with meningococcal group C polysaccharide vaccine.
    Cardeñosa N; Domínguez A; Martínez A; Alvarez J; Pañella H; Godoy P; Minguell S; Camps N; Vázquez JA;
    Infection; 2003 Dec; 31(6):392-7. PubMed ID: 14735381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Invasive meningococcal disease in Opolskie Voivodeship between 2005-2010].
    Posmyk U; Hryniewicz W; Skoczyńska A; Kumala R
    Pol Merkur Lekarski; 2012 May; 32(191):287-92. PubMed ID: 22779333
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Consensus building and recommendations based on the available epidemiology of meningococcal disease in Gulf Cooperation Council States.
    Memish ZA; Shibl AM
    Travel Med Infect Dis; 2011 Mar; 9(2):60-6. PubMed ID: 21345738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The current situation of meningococcal disease in Latin America and updated Global Meningococcal Initiative (GMI) recommendations.
    Sáfadi MA; O'Ryan M; Valenzuela Bravo MT; Brandileone MC; Gorla MC; de Lemos AP; Moreno G; Vazquez JA; López EL; Taha MK; Borrow R;
    Vaccine; 2015 Nov; 33(48):6529-36. PubMed ID: 26597036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of childhood meningococcal serogroup C conjugate vaccine programs in Canada.
    Bettinger JA; Scheifele DW; Le Saux N; Halperin SA; Vaudry W; Tsang R;
    Pediatr Infect Dis J; 2009 Mar; 28(3):220-4. PubMed ID: 19209096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Meningococcal infections in Scotland.
    Fallon RJ
    J Med Microbiol; 1988 Jul; 26(3):168-72. PubMed ID: 3134547
    [No Abstract]   [Full Text] [Related]  

  • 31. Meningococcal infection.
    O'Brien SJ; Smart LE
    Health Bull (Edinb); 1997 Jan; 55(1):7-9. PubMed ID: 9090171
    [No Abstract]   [Full Text] [Related]  

  • 32. Meningococcal disease in Canada. Surveillance summary to 1987.
    Varughese PV; Carter AO
    Can Dis Wkly Rep; 1989 Apr; 15(17):89-96. PubMed ID: 2720807
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Advances in vaccines and invasive disease in children].
    Moraga Llop FA
    Rev Esp Quimioter; 2001 Dec; 14(4):319-30. PubMed ID: 11856977
    [No Abstract]   [Full Text] [Related]  

  • 34. Meningococcal disease in São Paulo, Brazil.
    Costa W; Sacchi CT; Ramos S; Milagres L; Prigenzi LS
    NIPH Ann; 1991 Dec; 14(2):215-6; discussion 216-8, 222-4. PubMed ID: 1812434
    [No Abstract]   [Full Text] [Related]  

  • 35. Guidelines for control of meningococcal disease. Laboratory Centre for Disease Control. Canadian Consensus Conference on Meningococcal Disease.
    CMAJ; 1994 Jun; 150(11):1825-39. PubMed ID: 8199959
    [No Abstract]   [Full Text] [Related]  

  • 36. Meningococcal disease in Ontario during the winter of 1988-1989.
    Heimann GA; Mikel DE; Naus M; Goel V; Tischler M; Carlson JA; Schabas R; Pasut G; Borczyk A; Krishnan C
    Can Dis Wkly Rep; 1989 Mar; 15(11):59-62. PubMed ID: 2713946
    [No Abstract]   [Full Text] [Related]  

  • 37. [Acceptance of the new conjugate vaccines. Meningococcal and pneumococcal vaccines, in the cohort born in 1999, in the North Region of Portugal].
    De Queirós L; Castro L; Ferreira MC; Gonçalves G
    Acta Med Port; 2004; 17(1):49-53. PubMed ID: 15636727
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vaccinating adolescents against meningococcal disease in Canada: a cost-effectiveness analysis.
    De Wals P; Coudeville L; Trottier P; Chevat C; Erickson LJ; Nguyen VH
    Vaccine; 2007 Jul; 25(29):5433-40. PubMed ID: 17560695
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Changes in the evolution of meningococcal disease, 2001-2008, Catalonia (Spain).
    Martínez AI; Dominguez A; Oviedo M; Minguell S; Jansa JM; Codina G; Vazquez JA;
    Vaccine; 2009 May; 27(25-26):3496-8. PubMed ID: 19200816
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Severe outbreak of meningococcal disease in Auckland.
    Jackson G; Lennon D; Voss L; Flight R
    N Z Med J; 1987 Apr; 100(821):226. PubMed ID: 3455492
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.